ListarDepartament de Ciències Mèdiques por tema "Breast -- Cancer --Treatment"

The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes